SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M. Carcao, W. Re, B. Ewenstein, The role of previously untreated patient studies in understanding the development of FVIII inhibitors, Haemophilia, 2016, 22, 1
  2. 2
    S. M. Hashemi, K. Fischer, K. G. M. Moons, H. M. Berg, Improved prediction of inhibitor development in previously untreated patients with severe haemophilia A, Haemophilia, 2015, 21, 2
  3. 3
    Teresa Álvarez, Immaculada Soto, Jan Astermark, Non-genetic risk factors and their influence on the management of patients in the clinic, European Journal of Haematology, 2015, 94,
  4. 4
    C. Nakar, M. J. Manco-Johnson, A. Lail, S. Donfield, J. Maahs, Y. Chong, T. Blades, A. Shapiro, Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two US centres, Haemophilia, 2015, 21, 3
  5. 5
    Rolf Ljung, Nadine Gretenkort Andersson, The current status of prophylactic replacement therapy in children and adults with haemophilia, British Journal of Haematology, 2015, 169, 6
  6. 6
    Paola Giordano, Giuseppe Lassandro, Michele Valente, Angelo Claudio Molinari, Paola Ieranò, Antonio Coppola, Current Management of the Hemophilic Child: A Demanding Interlocutor. Quality of Life and Adequate Cost-Efficacy Analysis, Pediatric Hematology-Oncology, 2014, 31, 8, 687

    CrossRef

  7. You have free access to this content7
    H. M. Berg, Epidemiological aspects of inhibitor development redefine the clinical importance of inhibitors, Haemophilia, 2014, 20,
  8. 8
    A. Lochan, S. Macaulay, W. C. Chen, J. N. Mahlangu, A. Krause, Genetic factors influencing inhibitor development in a cohort of South African haemophilia A patients, Haemophilia, 2014, 20, 5
  9. 9
    Sonia López-Villareal, Osvelia Rodríguez-Luis, Norma Cruz-Fierro, Hemophilia A. Considerations in the dental management of pediatric patients. A case report., Journal Oral Of Research, 2014, 3, 3, 173

    CrossRef

  10. 10
    C. Vézina, M. Carcao, C. Infante-Rivard, D. Lillicrap, A. M. Stain, E. Paradis, J. Teitel, G. E. Rivard, Incidence and risk factors for inhibitor development in previously untreated severe haemophilia A patients born between 2005 and 2010, Haemophilia, 2014, 20, 6
  11. 11
    Karin Kurnik, Günter Auerswald, Wolfhart Kreuz, Inhibitors and prophylaxis in paediatric haemophilia patients: Focus on the German experience, Thrombosis Research, 2014, 134, S27

    CrossRef

  12. You have free access to this content12
    Peter W. Collins, Elizabeth Chalmers, Daniel P. Hart, Ri Liesner, Savita Rangarajan, Kate Talks, Mike Williams, Charles R. Hay, Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition), British Journal of Haematology, 2013, 160, 2
  13. 13
    Samantha C. Gouw, Johanna G. van der Bom, Rolf Ljung, Carmen Escuriola, Ana R. Cid, Ségolène Claeyssens-Donadel, Christel van Geet, Gili Kenet, Anne Mäkipernaa, Angelo Claudio Molinari, Wolfgang Muntean, Rainer Kobelt, George Rivard, Elena Santagostino, Angela Thomas, H. Marijke van den Berg, Factor VIII Products and Inhibitor Development in Severe Hemophilia A, New England Journal of Medicine, 2013, 368, 3, 231

    CrossRef

  14. 14
    Donna M. DiMichele, Inhibitors in childhood hemophilia A: Genetic and treatment-related risk factors for development and eradication, Pediatric Blood & Cancer, 2013, 60, S1
  15. 15
    R. Kruse-Jarres, Inhibitors: our greatest challenge. Can we minimize the incidence?, Haemophilia, 2013, 19,
  16. 16
    S. C. Gouw, H. M. van den Berg, K. Fischer, G. Auerswald, M. Carcao, E. Chalmers, H. Chambost, K. Kurnik, R. Liesner, P. Petrini, H. Platokouki, C. Altisent, J. Oldenburg, B. Nolan, R. P. Garrido, M. E. Mancuso, A. Rafowicz, M. Williams, N. Clausen, R. A. Middelburg, R. Ljung, J. G. van der Bom, Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study, Blood, 2013, 121, 20, 4046

    CrossRef

  17. 17
    Paola Giordano, Massimo Franchini, Giuseppe Lassandro, Maria Faienza, Roberto Valente, Angelo Molinari, Issues in pediatric haemophilia care, Italian Journal of Pediatrics, 2013, 39, 1, 24

    CrossRef

  18. 18
    W. Mondorf, W. Kalnins, R. Klamroth, Patient-reported outcomes of 182 adults with severe haemophilia in Germany comparing prophylactic vs. on-demand replacement therapy, Haemophilia, 2013, 19, 4
  19. 19
    N. Josephson, The hemophilias and their clinical management, Hematology, 2013, 2013, 1, 261

    CrossRef

  20. 20
    G. Auerswald, A. Thompson, M. Recht, D. Brown, R. Liesner, N. Guzman-Becerra, J. Dyck-Jones, B. Ewenstein, B. Abbuehl, Experience of Advate rAHF-PFM in previously untreated patients and minimally treated patients with haemophilia A, Thrombosis and Haemostasis, 2012, 107, 6, 1072

    CrossRef

  21. 21
    A. Inbal, J. Oldenburg, M. Carcao, A. Rosholm, R. Tehranchi, D. Nugent, Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency, Blood, 2012, 119, 22, 5111

    CrossRef

  22. 22
    Mohsen S. Elalfy, Nancy S. Elbarbary, Mohamed S. Eldebeiky, Azza S. El Danasoury, Risk of Bleeding and Inhibitor Development After Circumcision of Previously Untreated or Minimally Treated Severe Hemophilia A Children, Pediatric Hematology-Oncology, 2012, 29, 5, 485

    CrossRef

  23. 23
    A. COPPOLA, A. TAGLIAFERRI, M. FRANCHINI, Searching for the role of primary prophylaxis in preventing inhibitor development in hemophilia A, Journal of Thrombosis and Haemostasis, 2012, 10, 9
  24. 24
    M. E. MANCUSO, P. M. MANNUCCI, A. ROCINO, I. GARAGIOLA, A. TAGLIAFERRI, E. SANTAGOSTINO, Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A, Journal of Thrombosis and Haemostasis, 2012, 10, 5
  25. 25
    S. ZAPPA, M. McDANIEL, J. MARANDOLA, G. ALLEN, Treatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns survey, Haemophilia, 2012, 18, 3
  26. 26
    R. Kruse-Jarres, Current Controversies in the Formation and Treatment of Alloantibodies to Factor VIII in Congenital Hemophilia A, Hematology, 2011, 2011, 1, 407

    CrossRef

  27. 27
    C. L. ECKHARDT, J. G. van der BOM, M. VAN DER NAALD, M. PETERS, P. W. KAMPHUISEN, K. FIJNVANDRAAT, Surgery and inhibitor development in hemophilia A: a systematic review, Journal of Thrombosis and Haemostasis, 2011, 9, 10